Sarepta Therapeutics, Inc. (SRPT) Free cash flow 2016–2025
Sarepta Therapeutics, Inc. (SRPT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$307.5MFY2025 · since FY2016: -$251.2M → -$307.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$307.5M | +10.3% |
| FY2024 | -$342.7M | +40.6% |
| FY2023 | -$577.1M | -62.0% |
| FY2022 | -$356.2M | +26.1% |
| FY2021 | -$481.7M | -2006.5% |
| FY2020 | $25.3M | +104.9% |
| FY2019 | -$516.1M | -14.7% |
| FY2018 | -$449.8M | -84.4% |
| FY2017 | -$244.0M | +2.9% |
| FY2016 | -$251.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice